Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors
A novel class of non-nucleoside HCV NS5B polymerase inhibitors has been identified from screening. A co-crystal structure revealed an allosteric binding site in the protein that required a unique conformational change to accommodate inhibitor binding. Her